These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 23249970)

  • 1. Late gadolinium enhancement in cardiac sarcoidosis: characteristic magnetic resonance findings and relationship with left ventricular function.
    Watanabe E; Kimura F; Nakajima T; Hiroe M; Kasai Y; Nagata M; Kawana M; Hagiwara N
    J Thorac Imaging; 2013 Jan; 28(1):60-6. PubMed ID: 23249970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis.
    Ise T; Hasegawa T; Morita Y; Yamada N; Funada A; Takahama H; Amaki M; Kanzaki H; Okamura H; Kamakura S; Shimizu W; Anzai T; Kitakaze M
    Heart; 2014 Aug; 100(15):1165-72. PubMed ID: 24829369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late gadolinium enhancement from cardiac magnetic resonance in ischemic and non-ischemic cardiomyopathy.
    Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Udompunturak S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S33-8. PubMed ID: 21721426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac sarcoidosis detected by late gadolinium enhancement and prevalence of atrial arrhythmias.
    Cain MA; Metzl MD; Patel AR; Addetia K; Spencer KT; Sweiss NJ; Beshai JF
    Am J Cardiol; 2014 May; 113(9):1556-60. PubMed ID: 24731652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis.
    Smedema JP; Snoep G; van Kroonenburgh MP; van Geuns RJ; Dassen WR; Gorgels AP; Crijns HJ
    J Am Coll Cardiol; 2005 May; 45(10):1683-90. PubMed ID: 15893188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of late gadolinium enhancement MRI and quantitative T2 measurement in cardiac sarcoidosis.
    Yang Y; Safka K; Graham JJ; Roifman I; Zia MI; Wright GA; Balter M; Dick AJ; Connelly KA
    J Magn Reson Imaging; 2014 Mar; 39(3):609-16. PubMed ID: 23720077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QRS-based assessment of myocardial damage and adverse events associated with cardiac sarcoidosis.
    Sobue Y; Harada M; Koshikawa M; Ichikawa T; Yamamoto M; Okuda K; Kato Y; Sarai M; Watanabe E; Ozaki Y
    Heart Rhythm; 2015 Dec; 12(12):2499-507. PubMed ID: 26362576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac magnetic resonance imaging predicts recovery of left ventricular function in acute onset cardiomyopathy.
    McLellan AJ; McKenzie SC; Taylor AJ
    Heart Lung Circ; 2012 Jan; 21(1):30-5. PubMed ID: 22055931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.
    Greulich S; Deluigi CC; Gloekler S; Wahl A; Zürn C; Kramer U; Nothnagel D; Bültel H; Schumm J; Grün S; Ong P; Wagner A; Schneider S; Nassenstein K; Gawaz M; Sechtem U; Bruder O; Mahrholdt H
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sinus rhythm restores ventricular function in patients with cardiomyopathy and no late gadolinium enhancement on cardiac magnetic resonance imaging who undergo catheter ablation for atrial fibrillation.
    Ling LH; Taylor AJ; Ellims AH; Iles LM; McLellan AJ; Lee G; Kumar S; Lee G; Teh A; Medi C; Kaye DM; Kalman JM; Kistler PM
    Heart Rhythm; 2013 Sep; 10(9):1334-9. PubMed ID: 23811081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late gadolinium enhancement CMR in patients with tachycardia-induced cardiomyopathy caused by idiopathic ventricular arrhythmias.
    Hasdemir C; Yuksel A; Camli D; Kartal Y; Simsek E; Musayev O; Isayev E; Aydin M; Can LH
    Pacing Clin Electrophysiol; 2012 Apr; 35(4):465-70. PubMed ID: 22303908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction: Risk Stratification Using Cardiovascular Magnetic Resonance.
    Murtagh G; Laffin LJ; Beshai JF; Maffessanti F; Bonham CA; Patel AV; Yu Z; Addetia K; Mor-Avi V; Moss JD; Hogarth DK; Sweiss NJ; Lang RM; Patel AR
    Circ Cardiovasc Imaging; 2016 Jan; 9(1):e003738. PubMed ID: 26763280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI of cardiac sarcoidosis: basal and subepicardial localization of myocardial lesions and their effect on left ventricular function.
    Ichinose A; Otani H; Oikawa M; Takase K; Saito H; Shimokawa H; Takahashi S
    AJR Am J Roentgenol; 2008 Sep; 191(3):862-9. PubMed ID: 18716120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging.
    Mark PB; Johnston N; Groenning BA; Foster JE; Blyth KG; Martin TN; Steedman T; Dargie HJ; Jardine AG
    Kidney Int; 2006 May; 69(10):1839-45. PubMed ID: 16508657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of late gadolinium enhancement is associated with increased left ventricular wall stress and mass in patients with non-ischaemic dilated cardiomyopathy.
    Alter P; Rupp H; Adams P; Stoll F; Figiel JH; Klose KJ; Rominger MB; Maisch B
    Eur J Heart Fail; 2011 Sep; 13(9):937-44. PubMed ID: 21803756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.
    Rudolph A; Abdel-Aty H; Bohl S; Boyé P; Zagrosek A; Dietz R; Schulz-Menger J
    J Am Coll Cardiol; 2009 Jan; 53(3):284-91. PubMed ID: 19147047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late gadolinium enhancement in cardiac transplant patients is associated with adverse ventricular functional parameters and clinical outcomes.
    Butler CR; Kumar A; Toma M; Thompson R; Chow K; Isaac D; Kim D; Haykowsky M; Friedrich MG; Paterson I
    Can J Cardiol; 2013 Sep; 29(9):1076-83. PubMed ID: 23380296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular Magnetic Resonance Imaging Phenotypes and Long-term Outcomes in Patients With Suspected Cardiac Sarcoidosis.
    Athwal PSS; Chhikara S; Ismail MF; Ismail K; Ogugua FM; Kazmirczak F; Bawaskar PH; Elton AC; Markowitz J; von Wald L; Roukoz H; Bhargava M; Perlman D; Shenoy C
    JAMA Cardiol; 2022 Oct; 7(10):1057-1066. PubMed ID: 36103165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial fibrosis in isolated left ventricular non-compaction and its relation to disease severity.
    Nucifora G; Aquaro GD; Pingitore A; Masci PG; Lombardi M
    Eur J Heart Fail; 2011 Feb; 13(2):170-6. PubMed ID: 21208941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late gadolinium enhancement identified with cardiac magnetic resonance imaging in sarcoidosis patients is associated with long-term ventricular arrhythmia and sudden cardiac death.
    Nadel J; Lancefield T; Voskoboinik A; Taylor AJ
    Eur Heart J Cardiovasc Imaging; 2015 Jun; 16(6):634-41. PubMed ID: 25617029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.